Enhanced production of immunoglobulins
US11053288B2 · kind B2 · utility
0Cited by
57References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 3, 2017 |
| Grant date | Jul 6, 2021 |
| Priority date | — |
| Expiry date | Oct 5, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2510/02
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention provides methods and compositions for generating transgenic animals, including transgenic mammals, as well as plasma cells that allow for cell surface capture of secreted immunoglobulin molecules produced endogenously in the plasma cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.